Attached files
file | filename |
---|---|
EX-31.1 - NURX PHARMACEUTICALS, INC. | v172099_ex31-1.htm |
EX-31.2 - NURX PHARMACEUTICALS, INC. | v172099_ex31-2.htm |
EX-32.2 - NURX PHARMACEUTICALS, INC. | v172099_ex32-2.htm |
10-K/A - NURX PHARMACEUTICALS, INC. | v172099_10ka.htm |
Exhibit 32.1
CERTIFICATION PURSUANT
TO
18 U.S.C. SECTION
1350,
AS ADOPTED PURSUANT
TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF
2002
In connection with the annual report of
NuRx Pharmaceuticals, Inc. (the “Company”) on Form 10-K for the year ending
September 30, 2009, as filed with the Securities and Exchange Commission (the
“Report”), I, Harin Padma−Nathan, Chief Executive Officer of the Company,
certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, that:
1) The Report fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange Act of
1934; and
2) The information contained in the
Report fairly presents, in all material respects, the financial condition and
results of operations of the Company.
Date: January 28, 2010
/s/ Harin
Padma−Nathan
|
|
Name:
|
Harin
Padma−Nathan
|
Title:
|
President & Chief Executive
Officer
|
(principal executive
officer)
|